ChemInform Abstract: Coupling of the Anthracycline Antitumor Drug Menogaril to 2′-Deoxyguanosine Through Reductive Activation.

ChemInform ◽  
1990 ◽  
Vol 21 (5) ◽  
Author(s):  
M. EGHOLM ◽  
T. H. KOCH
1996 ◽  
Vol 93 ◽  
pp. 194-202
Author(s):  
E Renault ◽  
MP Fontaine-Aupart ◽  
M Gardès-Albert ◽  
C Rivalle ◽  
E Bisagni

1971 ◽  
Vol 246 (23) ◽  
pp. 7119-7124
Author(s):  
Frank O. Brady ◽  
Henry Jay Forman ◽  
Philip Feigelson
Keyword(s):  

ACS Catalysis ◽  
2021 ◽  
pp. 5472-5480
Author(s):  
Milena L. Czyz ◽  
Mitchell S. Taylor ◽  
Tyra H. Horngren ◽  
Anastasios Polyzos

2019 ◽  
Vol 2019 ◽  
pp. 1-7 ◽  
Author(s):  
Linda Zh. Nikoshvili ◽  
Nadezhda A. Nemygina ◽  
Tatiana E. Khudyakova ◽  
Irina Yu. Tiamina ◽  
Alexey V. Bykov ◽  
...  

This paper describes the synthesis of Pd-containing catalysts based on nonfunctionalized hypercrosslinked polystyrene via impregnation with Pd acetate. Developed Pd nanoparticulate catalyst allowed achieving conversion of aryl halide up to 90% in Suzuki cross-coupling reaction under mild conditions and at the absence of phase-transfer agents. During the selective hydrogenation of triple C-C bond of 2-methyl-3-butyn-2-ol, up to 96% selectivity with respect to corresponding olefinic alcohol was found at 95% conversion. The influences of the procedure of catalyst synthesis like precursor decomposition and reductive activation method on Pd nanoparticle formation are discussed.


Cancer ◽  
1993 ◽  
Vol 71 (7) ◽  
pp. 2217-2221 ◽  
Author(s):  
Ryuzo Ohno ◽  
Tohru Masaoka ◽  
Shigeru Shirakawa ◽  
Shinobu Sakamoto ◽  
Masami Hirano ◽  
...  

Nanomaterials ◽  
2021 ◽  
Vol 11 (3) ◽  
pp. 821
Author(s):  
Iyyakkannu Sivanesan ◽  
Manikandan Muthu ◽  
Judy Gopal ◽  
Nazim Hasan ◽  
Syed Kashif Ali ◽  
...  

Chitin (poly-N-acetyl-D-glucosamine) is the second (after cellulose) most abundant organic polymer. In its deacetylated form—chitosan—becomes a very interesting material for medical use. The chitosan nano-structures whose preparation is described in this article shows unique biomedical value. The preparation of nanochitosan, as well as the most vital biomedical applications (antitumor, drug delivery and other medical uses), have been discussed in this review. The challenges confronting the progress of nanochitosan from benchtop to bedside clinical settings have been evaluated. The need for inclusion of nano aspects into chitosan research, with improvisation from nanotechnological inputs has been prescribed for breaking down the limitations. Future perspectives of nanochitosan and the challenges facing nanochitosan applications and the areas needing research focus have been highlighted.


Sign in / Sign up

Export Citation Format

Share Document